Lucrative Growth Opportunities in the Non-invasive Prenatal Testing (NIPT) Market
Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
(firmenpresse) - The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.
The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market.
The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.
On the basis of application, the NIPT market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest application segment and is slated to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing maternal age and rising incidence of chromosomal abnormalities.
To get Details (at) https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html
Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.03.2019 - 19:17 Uhr
Sprache: Deutsch
News-ID 589212
Anzahl Zeichen: 4476
contact information:
Phone: +44-800-368-9399
Kategorie:
Healthcare & Medical
Typ of Press Release: Success
type of sending: don't
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Lucrative Growth Opportunities in the Non-invasive Prenatal Testing (NIPT) Market"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
